StockData
PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31

ProQR Therapeutics N.V.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026
$1.31+0.00 (0.00%)

Close on Oct 19, 2026

ProQR Therapeutics N.V. revenue by segment

No segment breakdown reported

ProQR Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.